U.S. IV Infusion Products Market Positioned for Expansion with Growth in Home Healthcare and Chronic Disease Management

The U.S. IV Infusion Products market represents a critical segment within the broader healthcare industry, responding dynamically to the rising demand for intravenous therapies across hospitals, ambulatory care centers, and homecare settings. With increasing prevalence of chronic diseases, advances in medical technology, and heightened ambulatory healthcare services, the industry size is steadily expanding. The Global U.S. IV Infusion Products Market size is estimated to be valued at USD 7,885.4 million in 2025 and is expected to reach USD 10,238.5 million by 2032, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2025 to 2032. Such market growth reflects a combination of evolving market drivers, innovation in infusion technologies, and increased adoption of ambulatory infusion devices.

Request for Sample Copy of the Report here: https://www.coherentmarketinsights.com/insight/request-sample/4700

➤Analyst Opinion

● The surge in outpatient infusion therapies is a key demand-side indicator propelling the U.S. IV Infusion Products market revenue. For instance, data from 2024 showed a 12% rise in home infusion services, directly boosting market share for ambulatory infusion pumps and disposables. This trend is driven by cost-effectiveness and patient preference, with hospital IV infusions witnessing a moderate decline in use.

● Technological innovation in infusion devices, such as smart pumps with enhanced safety features, is increasing production capacity and pricing leverage. Terumo Corporation and Becton Dickinson and Company introduced advanced safety-engineered infusion sets in early 2025, contributing to a 6% year-over-year revenue increase in the infusion pumps segment.

● Supply chain optimization and regulatory approvals remain critical micro-indicators influencing the market forecast. In 2023, faster FDA clearances for infusion catheter innovations shortened time-to-market by 15%, allowing companies like AngioDynamics Inc. to capture early market share in niche therapeutic areas.

● The growing prevalence of chronic illnesses, including diabetes and cancer, demands complex infusion therapies across multiple care settings. The American Cancer Society reported a 5% increase in outpatient chemotherapy infusions in the U.S. during 2024, intensifying demand for precision IV infusion products and expanding the market scope.

➤Market Taxonomy and Regional coverage of Report

● Comprehensive Taxonomy of the Report:
» By Product Type: Infusion Pumps, Infusion Sets & Catheters, IV Cannulas, Accessories & Consumables, and Others
» By Application: Hospital-Based Infusion, Ambulatory Care Infusion, Homecare Infusion, and Emergency Care
» By End-User: Hospitals, Ambulatory Surgical Centers, Homecare Settings, Long Term Care Facilities, and Clinics

● Regional and Country Analysis:
» North America: U.S. and Canada
» Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
» Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
» Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
» Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/4700

➤Leading Companies of the Market

● AngioDynamics Inc.
● Kimal
● Terumo Corporation
● Teleflex Inc.
● Becton Dickinson and Company
● Cook Group
● Nipro Corporation
● ZOLL Medical Corporation
● B. Braun Medical Inc.
● AdvaCare Pharma
● PL Medical Co.LLC
● Greiner Bio-One International GmbH
● EMED Technologies Corporation
● CODAN Companies
● Smiths Group plc

● Several leading companies have adopted aggressive market growth strategies centered around product innovation and strategic acquisitions. For example, Becton Dickinson and Company's 2024 acquisition of a mid-sized infusion technology firm expanded its product portfolio and regional footprint, leading to an 8% increase in market share within one year. Likewise, Terumo Corporation invested approx. USD 45 million in R&D focusing on miniaturization and ergonomic design in infusion pumps, resulting in enhanced market revenue in 2025.

➤Key Growth Drivers Fuelling Market Expansion

The U.S. IV Infusion Products market growth is underpinned by several critical drivers. First, the increasing preference for home healthcare and ambulatory infusion therapies has significantly expanded the demand for portable and user-friendly infusion pumps, contributing to an estimated 14% rise in ambulatory infusion product sales during 2024. Second, technological advancements incorporating wireless connectivity and safety mechanisms are elevating product adoption, supported by a 22% growth in smart IV infusion devices reported by a leading healthcare analytics firm in 2025. Third, rising chronic conditions such as cancer, renal, and cardiovascular diseases are intensifying the requirement for long-term IV therapy solutions, with oncology-related infusion treatments growing at a 6.5% CAGR in recent years. Lastly, increasing healthcare expenditure and government initiatives encouraging outpatient care services are amplifying the overall industry size and market revenue potential, as evidenced by USD 120 billion federal funding allocated to home healthcare programs in the U.S. in 2023.

➤Key Reasons for Buying the U.S. IV Infusion Products Report

✦ Comprehensive analysis of the changing competitive landscape
✦ Assists in decision-making processes for the businesses along with detailed strategic planning methodologies
✦ The report offers forecast data and an assessment of the U.S. IV Infusion Products
✦ Helps in understanding the key product segments and their estimated growth rate
✦ In-depth analysis of market drivers, restraints, trends, and opportunities
✦ Comprehensive regional analysis of the U.S. IV Infusion Products
✦ Extensive profiling of the key stakeholders of the business sphere
✦ Detailed analysis of the factors influencing the growth of the U.S. IV Infusion Products

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/4700

➤ Emerging Trends and Market Shift

The U.S. IV Infusion Products market is witnessing a significant shift with emerging trends that are redefining the market dynamics. In 2024 and 2025, the rise of integrated IV infusion management systems combining device hardware with cloud-based analytics has facilitated real-time monitoring and error reduction, significantly improving patient outcomes. Additionally, market companies are increasingly emphasizing sustainability by developing eco-friendly disposables, responding to regulatory pressures and consumer demand. The emergence of personalized infusion therapies, leveraging data analytics for dosage customization, is becoming mainstream and is supported by clinical trials showing a 15% improvement in therapeutic efficacy. The ongoing expansion of telehealth services post-pandemic has brought infusion devices into remote patient management frameworks, offering growth pathways and shifting competitive strategies.

➤High-Impact Market Opportunities by Segment and Region

Within the infusion pumps segment, there is a high-impact opportunity driven by the growing adoption of ambulatory and wearable infusion devices. These compact devices enable patients to receive ongoing IV treatments without hospitalization, a sector that recorded an 18% uplift in revenues between 2023 and 2025. In the infusion sets & catheters segment, demand for precision-engineered, safety-engineered catheters presents an avenue for differentiated product development, with B. Braun Medical Inc. reporting a 12% increase in infusion set sales due to such innovations in 2024. The hospital-based infusion application segment holds substantial opportunity as healthcare facilities upgrade infrastructure with integrated IV infusion management platforms, forecasted to grow robustly through 2032. Regionally, North America, led by the U.S., offers immense market potential supported by advanced healthcare infrastructure and increased healthcare spending, projected to hold over 65% of the market share in 2025 and beyond.

❓ Frequently Asked Questions

1. Who are the dominant players in the U.S. IV Infusion Products market?
The leading market companies include AngioDynamics Inc., Terumo Corporation, Becton Dickinson and Company, and B. Braun Medical Inc., among others, each commanding significant market share through innovation and strategic growth initiatives.

2. What will be the size of the U.S. IV Infusion Products market in the coming years?
The market revenue is forecasted to grow from USD 7,885.4 million in 2025 to USD 10,238.5 million by 2032, reflecting a CAGR of 3.8% driven by expanding homecare and ambulatory infusion therapies.

3. Which end users industry has the largest growth opportunity?
Ambulatory care settings and homecare infusion represent the largest growth opportunity segments, supported by increasing patient preference for outpatient therapies and evolving healthcare models.

4. How will market development trends evolve over the next five years?
Industry trends will focus on smart infusion devices with connectivity, personalized dosing, sustainability initiatives, and integration with telehealth, reshaping the U.S. IV Infusion Products market landscape.

5. What is the nature of the competitive landscape and challenges in the U.S. IV Infusion Products market?
The competitive landscape is characterized by innovation-driven market players facing challenges such as regulatory compliances, pricing pressures, and the need for rapid technological upgrades.

6. What go-to-market strategies are commonly adopted in the U.S. IV Infusion Products market?
Strategies include product portfolio diversification, strategic acquisitions, partnerships for technology integration, and expanding sales in ambulatory and home infusion markets.

This detailed market report delivers crucial insights into the market size, market share, and industry trends, providing actionable market intelligence for strategic growth and informed decision-making in the U.S. IV Infusion Products sector.

✍️ PR Authored By:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report.

About Us:

With a proven excellence in market research, Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

☎️ Contact Us:

533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: + 12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-8-7924-7805
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com

This release was published on openPR.